Home > Courses > HBV & HIV: A Tale of Two Viruses and Many Drugs!

HBV & HIV: A Tale of Two Viruses and Many Drugs!

HBV & HIV: A Tale of Two Viruses and Many Drugs!
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 11/17/2009
Review Date: 11/17/2009
  • Douglas T. Dieterich, MD
    Professor of Medicine
    Icahn School of Medicine at Mount Sinai, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Explain the importance of diagnosing and evaluating HIV / HBV coinfection.
  2. Describe how to treat chronic hepatitis B in the setting of HIV coinfection.
  3. Discern renal toxicity issues in treating HIV & HBV.
  4. Explain the importance of screening for hepatocellular carcinoma (HCC) in HIV/HBV coinfected patients.
Presenter Bio
Douglas Dieterich, MD
Douglas T. Dieterich, MD is currently Professor of Medicine in the Division of Hepatology, with a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases at the Icahn School of Medicine at Mount Sinai in New York City. He is an investigator for several ongoing studies evaluating the safety and efficacy of various antiviral treatment regimens for chronic hepatitis B & C. He has served on several committees of the AIDS Clinical Trials Group at the National Institutes of Health (NIH), including the Steering Committee of the Opportunistic Infections Core Committee and the Cytomegalovirus (CMV) Committee. He was Chair and Co-Chair, respectively, of the Enteric Parasites Committee and the Protozoan Committee. He also served on the NIH Study Sections for CMV and cryptosporidiosis. Widely published, Dr. Dieterich is the author of numerous journal articles, abstracts and book chapters on viral hepatitis and AIDS associated infections of the gastrointestinal tract and liver.
PRN Learning Modules